ABMD logo

Abiomed (ABMD) Selling, General & Administrative Expenses

Annual SG&A

$423.49 M
+$89.30 M+26.72%

31 March 2022

3-Year Change

+26.72%
ABMD annual selling, general & administrative expenses is up +26.72% over the past 3 years

All-time High

$423.49 M
ABMD annual selling, general & administrative expenses is currently at an all-time high
Annual Total Expenses$775.05 M
ABMD annual total expenses is $775.05 million
Annual Operating Expenses$586.89 M
ABMD annual total operating expenses is $586.89 million
Annual Revenue$1.03 B
ABMD annual revenue is $1.03 billion
Annual Net Income$136.50 M
ABMD annual net profit is $136.50 million

ABMD Selling, General & Administrative Expenses Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly SG&A

$116.96 M
-$1.04 M-0.88%

30 September 2022

3-Year Change

+8.68%
ABMD quarterly selling, general & administrative expenses is up +8.68% over the past 3 years

All-time High

$118.00 M
ABMD quarterly selling, general & administrative expenses is currently -0.88% below its historical high of $118.00 million
Quarterly Total Expenses$207.93 M
ABMD quarterly total expenses is $207.93 million
Quarterly Operating Expenses$159.05 M
ABMD quarterly total operating expenses is $159.05 million
Quarterly Revenue$265.92 M
ABMD quarterly revenue is $265.92 million
Quarterly Net Income$106.13 M
ABMD quarterly net profit is $106.13 million

ABMD Quarterly SG&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM SG&A

$4.01 B
+$266.76 M+7.12%

30 September 2022

3-Year Change

+868.72%
ABMD TTM selling, general & administrative expenses is up +868.72% over the past 3 years

All-time High

$452.18 M
Annual Total Expenses$775.05 M
ABMD annual total expenses is $775.05 million
Annual Operating Expenses$586.89 M
ABMD annual total operating expenses is $586.89 million
TTM Revenue$1.07 B
ABMD TTM revenue is $1.07 billion
TTM Net Income$266.76 M
ABMD TTM net profit is $266.76 million

ABMD TTM SG&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ABMD Selling, General & Administrative Expenses Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year---
3 y3 years+26.7%+8.7%+868.7%
5 y5 years+31.7%+36.5%+1083.8%

ABMD Selling, General & Administrative Expenses High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years
5 y5 years
alltimeall timeat high-0.9%+787.5%

Abiomed Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Sept 2022
-
$116.96 M(-0.9%)
$452.18 M(+3.2%)
June 2022
-
$118.00 M(+7.7%)
$438.00 M(+3.4%)
Mar 2022
$423.49 M(+26.7%)
$109.61 M(+1.8%)
$423.49 M(+2.2%)
Dec 2021
-
$107.62 M(+4.7%)
$414.25 M(+5.5%)
Sept 2021
-
$102.78 M(-0.7%)
$392.83 M(+6.4%)
June 2021
-
$103.48 M(+3.1%)
$369.22 M(+10.5%)
Mar 2021
$334.18 M(-2.2%)
$100.37 M(+16.4%)
$334.18 M(+5.2%)
Dec 2020
-
$86.20 M(+8.9%)
$317.70 M(+0.2%)
Sept 2020
-
$79.17 M(+15.7%)
$317.18 M(-2.1%)
June 2020
-
$68.44 M(-18.4%)
$323.97 M(-5.2%)
Mar 2020
$341.60 M(+6.2%)
$83.89 M(-2.1%)
$341.60 M(+0.8%)
Dec 2019
-
$85.67 M(-0.3%)
$339.00 M(+1.6%)
Sept 2019
-
$85.96 M(-0.1%)
$333.55 M(+2.2%)
June 2019
-
$86.08 M(+5.9%)
$326.49 M(+1.5%)
Mar 2019
$321.55 M(+22.4%)
$81.30 M(+1.3%)
$321.55 M(+1.8%)
Dec 2018
-
$80.22 M(+1.7%)
$315.75 M(+4.5%)
Sept 2018
-
$78.89 M(-2.8%)
$302.09 M(+6.6%)
June 2018
-
$81.14 M(+7.5%)
$283.28 M(+7.8%)
Mar 2018
$262.73 M(+20.4%)
$75.50 M(+13.4%)
$262.73 M(+6.2%)
Dec 2017
-
$66.56 M(+10.8%)
$247.33 M(+5.4%)
Sept 2017
-
$60.08 M(-0.9%)
$234.71 M(+3.1%)
June 2017
-
$60.60 M(+0.8%)
$227.72 M(+4.4%)
Mar 2017
$218.15 M(+32.8%)
$60.10 M(+11.4%)
$218.15 M(+7.3%)
Dec 2016
-
$53.94 M(+1.6%)
$203.31 M(+6.3%)
Sept 2016
-
$53.09 M(+4.0%)
$191.23 M(+7.4%)
June 2016
-
$51.03 M(+12.8%)
$177.97 M(+8.3%)
Mar 2016
$164.26 M(+30.6%)
$45.26 M(+8.1%)
$164.26 M(+7.0%)
Dec 2015
-
$41.85 M(+5.1%)
$153.54 M(+8.3%)
Sept 2015
-
$39.83 M(+6.7%)
$141.83 M(+7.9%)
June 2015
-
$37.32 M(+8.1%)
$131.45 M(+4.6%)
Mar 2015
$125.73 M(+17.2%)
$34.53 M(+14.6%)
$125.73 M(+4.8%)
Dec 2014
-
$30.14 M(+2.3%)
$119.91 M(+5.1%)
Sept 2014
-
$29.45 M(-6.8%)
$114.14 M(+2.9%)
June 2014
-
$31.60 M(+10.0%)
$110.88 M(+3.4%)
Mar 2014
$107.25 M(+27.3%)
$28.72 M(+17.9%)
$107.25 M(+4.7%)
Dec 2013
-
$24.36 M(-7.0%)
$102.42 M(+3.5%)
Sept 2013
-
$26.20 M(-6.3%)
$99.00 M(+8.5%)
June 2013
-
$27.97 M(+17.0%)
$91.24 M(+8.3%)
Mar 2013
$84.23 M(+17.5%)
$23.89 M(+14.1%)
$84.23 M(+4.8%)
Dec 2012
-
$20.94 M(+13.6%)
$80.36 M(+4.9%)
Sept 2012
-
$18.44 M(-12.0%)
$76.60 M(+2.8%)
June 2012
-
$20.95 M(+4.6%)
$74.49 M(+3.9%)
Mar 2012
$71.71 M(+15.1%)
$20.03 M(+16.6%)
$71.71 M(+4.6%)
Dec 2011
-
$17.18 M(+5.3%)
$68.57 M(+2.4%)
Sept 2011
-
$16.32 M(-10.2%)
$66.98 M(+3.5%)
June 2011
-
$18.18 M(+7.6%)
$64.71 M(+3.9%)
Mar 2011
$62.29 M(+2.4%)
$16.89 M(+8.3%)
$62.29 M(+3.4%)
Dec 2010
-
$15.59 M(+10.9%)
$60.26 M(+0.7%)
Sept 2010
-
$14.05 M(-10.8%)
$59.86 M(-1.3%)
June 2010
-
$15.75 M(+6.0%)
$60.62 M(-0.4%)
Mar 2010
$60.84 M(+9.9%)
$14.86 M(-2.1%)
$60.84 M(+0.2%)
Dec 2009
-
$15.19 M(+2.5%)
$60.69 M(+3.3%)
Sept 2009
-
$14.82 M(-7.2%)
$58.73 M(+1.6%)
June 2009
-
$15.97 M(+8.5%)
$57.81 M(+4.4%)
Mar 2009
$55.36 M(+5.1%)
$14.72 M(+11.3%)
$55.36 M(+0.5%)
Dec 2008
-
$13.23 M(-4.8%)
$55.06 M(-0.6%)
Sept 2008
-
$13.90 M(+2.8%)
$55.37 M(+3.1%)
June 2008
-
$13.51 M(-6.3%)
$53.73 M(+2.0%)
Mar 2008
$52.66 M(+24.1%)
$14.42 M(+6.5%)
$52.66 M(+6.7%)
Dec 2007
-
$13.54 M(+10.5%)
$49.33 M(+5.6%)
Sept 2007
-
$12.26 M(-1.5%)
$46.71 M(+2.7%)
June 2007
-
$12.44 M(+12.2%)
$45.50 M(+7.2%)
Mar 2007
$42.45 M
$11.09 M(+1.6%)
$42.45 M(+4.3%)
Dec 2006
-
$10.92 M(-1.2%)
$40.69 M(+9.4%)
Sept 2006
-
$11.05 M(+17.6%)
$37.20 M(+12.7%)
DateAnnualQuarterlyTTM
June 2006
-
$9.39 M(+0.6%)
$32.99 M(+6.8%)
Mar 2006
$30.92 M(+66.2%)
$9.34 M(+25.8%)
$30.91 M(+15.8%)
Dec 2005
-
$7.42 M(+8.4%)
$26.68 M(+13.4%)
Sept 2005
-
$6.84 M(-6.3%)
$23.52 M(+12.0%)
June 2005
-
$7.30 M(+42.9%)
$20.99 M(+12.8%)
Mar 2005
$18.61 M(+31.9%)
$5.11 M(+20.1%)
$18.61 M(+6.3%)
Dec 2004
-
$4.26 M(-1.4%)
$17.50 M(+3.4%)
Sept 2004
-
$4.32 M(-12.2%)
$16.92 M(+7.0%)
June 2004
-
$4.92 M(+22.8%)
$15.82 M(+12.2%)
Mar 2004
$14.10 M(-4.4%)
$4.00 M(+8.8%)
$14.10 M(+2.0%)
Dec 2003
-
$3.68 M(+14.4%)
$13.82 M(+3.0%)
Sept 2003
-
$3.22 M(+0.5%)
$13.41 M(-6.9%)
June 2003
-
$3.20 M(-14.0%)
$14.41 M(-2.3%)
Mar 2003
$14.75 M(-8.2%)
$3.72 M(+13.7%)
$14.75 M(-2.8%)
Dec 2002
-
$3.27 M(-22.4%)
$15.17 M(-3.9%)
Sept 2002
-
$4.21 M(+19.0%)
$15.78 M(+2.0%)
June 2002
-
$3.54 M(-14.4%)
$15.46 M(-3.7%)
Mar 2002
$16.07 M(+28.8%)
$4.14 M(+6.6%)
$16.07 M(+3.4%)
Dec 2001
-
$3.88 M(-0.4%)
$15.54 M(+6.6%)
Sept 2001
-
$3.90 M(-5.9%)
$14.58 M(+6.9%)
June 2001
-
$4.14 M(+14.6%)
$13.64 M(+9.4%)
Mar 2001
$12.47 M(-0.7%)
$3.62 M(+23.8%)
$12.47 M(-0.4%)
Dec 2000
-
$2.92 M(-1.4%)
$12.52 M(-4.4%)
Sept 2000
-
$2.96 M(-0.6%)
$13.10 M(+0.5%)
June 2000
-
$2.98 M(-18.7%)
$13.04 M(+3.8%)
Mar 2000
$12.56 M(+28.2%)
$3.66 M(+4.6%)
$12.56 M(+5.9%)
Dec 1999
-
$3.50 M(+20.7%)
$11.86 M(+11.2%)
Sept 1999
-
$2.90 M(+16.1%)
$10.66 M(+5.9%)
June 1999
-
$2.50 M(-15.6%)
$10.07 M(+2.7%)
Mar 1999
$9.80 M(+7.7%)
$2.96 M(+28.6%)
$9.80 M(+6.1%)
Dec 1998
-
$2.30 M(-0.2%)
$9.24 M(+2.2%)
Sept 1998
-
$2.31 M(+3.3%)
$9.04 M(-4.2%)
June 1998
-
$2.23 M(-7.0%)
$9.43 M(+3.6%)
Mar 1998
$9.10 M(+49.2%)
$2.40 M(+14.3%)
$9.10 M(+14.3%)
Dec 1997
-
$2.10 M(-22.2%)
$7.96 M(+6.5%)
Sept 1997
-
$2.70 M(+42.1%)
$7.47 M(+15.3%)
June 1997
-
$1.90 M(+51.0%)
$6.48 M(+6.6%)
Mar 1997
$6.10 M(+6.3%)
$1.26 M(-22.0%)
$6.08 M(-5.4%)
Dec 1996
-
$1.61 M(-5.7%)
$6.43 M(+2.0%)
Sept 1996
-
$1.71 M(+14.0%)
$6.30 M(+4.9%)
June 1996
-
$1.50 M(-6.6%)
$6.01 M(+4.9%)
Mar 1996
$5.74 M(+33.5%)
$1.61 M(+8.3%)
$5.72 M(+14.1%)
Dec 1995
-
$1.48 M(+4.9%)
$5.02 M(+6.0%)
Sept 1995
-
$1.41 M(+16.2%)
$4.73 M(+7.1%)
June 1995
-
$1.22 M(+35.2%)
$4.42 M(+5.2%)
Mar 1995
$4.30 M(-2.3%)
$900.00 K(-25.0%)
$4.20 M(-2.3%)
Dec 1994
-
$1.20 M(+9.1%)
$4.30 M(+7.5%)
Sept 1994
-
$1.10 M(+10.0%)
$4.00 M(-2.4%)
June 1994
-
$1.00 M(0.0%)
$4.10 M(-4.7%)
Mar 1994
$4.40 M(-4.3%)
$1.00 M(+11.1%)
$4.30 M(-15.7%)
Dec 1993
-
$900.00 K(-25.0%)
$5.10 M(0.0%)
Sept 1993
-
$1.20 M(0.0%)
$5.10 M(+4.1%)
June 1993
-
$1.20 M(-33.3%)
$4.90 M(+6.5%)
Mar 1993
$4.60 M(-28.1%)
$1.80 M(+100.0%)
$4.60 M(+2.2%)
Dec 1992
-
$900.00 K(-10.0%)
$4.50 M(-15.1%)
Sept 1992
-
$1.00 M(+11.1%)
$5.30 M(+1.9%)
June 1992
-
$900.00 K(-47.1%)
$5.20 M(+2.0%)
Mar 1992
$6.40 M(-27.3%)
$1.70 M(0.0%)
$5.10 M(+50.0%)
Dec 1991
-
$1.70 M(+88.9%)
$3.40 M(+100.0%)
Sept 1991
-
$900.00 K(+12.5%)
$1.70 M(+112.5%)
June 1991
-
$800.00 K
$800.00 K
Mar 1991
$8.80 M(+69.2%)
-
-
Mar 1990
$5.20 M(+8.3%)
-
-
Mar 1989
$4.80 M(-5.9%)
-
-
Mar 1988
$5.10 M(+466.7%)
-
-
Mar 1987
$900.00 K
-
-

FAQ

  • What is Abiomed annual selling, general & administrative expenses?
  • What is the all time high annual SG&A for Abiomed?
  • What is Abiomed quarterly selling, general & administrative expenses?
  • What is the all time high quarterly SG&A for Abiomed?
  • What is Abiomed TTM selling, general & administrative expenses?
  • What is the all time high TTM SG&A for Abiomed?

What is Abiomed annual selling, general & administrative expenses?

The current annual SG&A of ABMD is $423.49 M

What is the all time high annual SG&A for Abiomed?

Abiomed all-time high annual selling, general & administrative expenses is $423.49 M

What is Abiomed quarterly selling, general & administrative expenses?

The current quarterly SG&A of ABMD is $116.96 M

What is the all time high quarterly SG&A for Abiomed?

Abiomed all-time high quarterly selling, general & administrative expenses is $118.00 M

What is Abiomed TTM selling, general & administrative expenses?

The current TTM SG&A of ABMD is $4.01 B

What is the all time high TTM SG&A for Abiomed?

Abiomed all-time high TTM selling, general & administrative expenses is $452.18 M